We are live on
!
Find out more
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
76 hedge funds and large institutions have $135M invested in Novelion Therapeutics Inc. Common Shares in 2017 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
2,756% more call options, than puts
Call options by funds: $257K | Put options by funds: $9K
91% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 11
15% more funds holding
Funds holding: 66 → 76 (+10)
6% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 18
7% less capital invested
Capital invested by funds: $146M → $135M (-$10.2M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
76
Holders Change
+10
Holders Change %
+15.15%
% of All Funds
1.9%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.07%
New
21
Increased
17
Reduced
18
Closed
11
Calls
$257K
Puts
$9K
Net Calls
+$248K
Net Calls Change
+$211K
Top Buyers
| 1 |
BlackRock
New York
|
+$6.31M |
| 2 |
HCM
Highbridge Capital Management
New York
|
+$5.12M |
| 3 |
Morgan Stanley
New York
|
+$4.45M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.81M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.31M |
Top Sellers
| 1 |
KCM
Kingstown Capital Management
New York
|
-$6.44M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$2.98M |
| 3 |
Millennium Management
New York
|
-$1.25M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$893K |
| 5 |
Two Sigma Investments
New York
|
-$709K |
